China Pharma Holdings (CPHI) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts CPHI Hot Sheet
Price: $1.08 -4.42%
Financial Fact:
Bad debt expense (benefit): -69.9K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Bad debt expense (benefit): -69.9K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
China Pharma Holdings (NYSE: CPHI) reported Q2 EPS of $0.11, in-line with the analyst estimate of $0.11. Revenue for the quarter came in at $19.6 million versus the consensus estimate of $19.46 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- InspireMD (NSPR) Tops Q2 EPS by 1c
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
